Spreading the word about lymphoedema

March is Lymphoedema Awareness Month and the founder of Cancer Rehabilitation & Lymphatic Solutions (CRLS) at Erina, Kate Perkins, is spreading the word about the value of early detection.

Leading lymphoedema expert Perkins, who has more than 10 years’ experience in the field, also founded Coastal Rehab Hub and the Bounce Back From Breast Cancer Program.

She co-founded OncoLaser™, an innovative system which integrates Photobiomodulation Therapy (PBMT) using MLS® Laser Therapy to address cancer treatment side effects such as pain, inflammation and lymphoedema.

Lymphoedema is a chronic condition which causes swelling due to a compromised lymphatic system, often following cancer treatment.

Research suggests that over 50% of head and neck cancer (HNC) patients will develop lymphoedema following treatment, affecting their ability to swallow, speak, and breathe.

Approximately one in five breast cancer survivors will experience Breast Cancer-Related Lymphoedema (BCRL), leading to arm and chest swelling, discomfort, and functional limitations.

If not monitored for early intervention, BCRL can become chronic and significantly impact quality of life.

“Too many patients don’t realise they’re at risk until the swelling starts, and by then, it’s much harder to manage,” Perkins said.

“By integrating early intervention strategies and targeted therapies, we can significantly reduce the impact of lymphoedema on a person’s quality of life.”

Perkins and her team combine traditional lymphoedema treatments with advanced medical technology, ensuring patients receive the best possible outcomes.

One of the most promising developments is OncoLaser™, which helps reduce swelling, improve circulation, and support long-term lymphatic health, both minimising the onset of lymphoedema and relieving existing symptoms.

“OncoLaser™ is changing the way we approach lymphoedema care,” Perkins said.

“It’s not just about managing symptoms – it’s about actively improving outcomes, reducing discomfort, and getting people back to living their lives.”

CRLS also integrates SOZO bioimpedance spectroscopy, an advanced technology which detects fluid buildup before physical symptoms appear, allowing for earlier intervention and better long-term management.

To learn more about lymphoedema and early detection strategies, visit Cancer Rehabilitation & Lymphatic Solutions at www.crls.au, or contact Kate Perkins on 4312 7033 for expert treatment.